Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

AMAM | Ambrx Biopharma Inc ADR

Index- P/E- EPS (ttm)-2.02 Insider Own4.01% Shs Outstand61.75M Perf Week4.10%
Market Cap690.37M Forward P/E- EPS next Y-0.20 Insider Trans402.47% Shs Float59.27M Perf Month-20.82%
Income-78.00M PEG- EPS next Q-0.05 Inst Own78.68% Short Float / Ratio1.76% / 2.69 Perf Quarter-30.82%
Sales7.40M P/S93.29 EPS this Y36.21% Inst Trans-1.30% Short Interest1.04M Perf Half Y25.34%
Book/sh4.05 P/B2.76 EPS next Y-6.31% ROA-39.56% Target Price23.38 Perf Year916.36%
Cash/sh3.82 P/C2.93 EPS next 5Y21.70% ROE-50.68% 52W Range0.38 - 16.86 Perf YTD392.51%
Dividend- P/FCF- EPS past 5Y- ROI-30.05% 52W High-33.69% Beta-2.36
Dividend %- Quick Ratio13.28 Sales past 5Y-4.53% Gross Margin38.76% 52W Low2842.11% ATR0.89
Employees66 Current Ratio13.28 Sales Q/Q- Oper. Margin-901.66% RSI (14)43.49 Volatility5.60% 8.92%
OptionableYes Debt/Eq0.04 EPS Q/Q- Profit Margin-1053.72% Rel Volume0.00 Prev Close11.18
ShortableYes LT Debt/Eq0.04 Earnings- Payout- Avg Volume387.80K Price11.18
Recom1.33 SMA20-2.02% SMA50-15.06% SMA20012.72% Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Sep-25-23Initiated JMP Securities Mkt Outperform $15
Sep-12-23Initiated BTIG Research Buy $26
Jul-31-23Initiated RBC Capital Mkts Outperform $29
Jun-14-23Initiated B. Riley Securities Buy $26
Jun-02-23Initiated Oppenheimer Outperform $30
May-19-23Initiated Cantor Fitzgerald Overweight $25
Apr-07-22Initiated Robert W. Baird Outperform $16
Feb-28-22Initiated Goldman Neutral $6
Jul-13-21Initiated Goldman Buy $53
Jul-13-21Initiated Cowen Outperform
Jul-13-21Initiated BofA Securities Buy $26
Oct-01-23 11:00AM
Sep-26-23 08:30AM
Sep-18-23 08:00AM
Sep-05-23 08:30AM
Aug-11-23 09:20AM
08:30AM Loading…
Aug-01-23 08:30AM
Jul-31-23 09:51AM
Jul-28-23 08:30AM
Jul-19-23 09:03AM
Jul-02-23 05:05AM
Jun-28-23 08:30AM
Jun-05-23 08:30AM
May-30-23 09:01AM
May-24-23 08:30AM
May-18-23 04:05PM
04:23PM Loading…
May-11-23 04:23PM
May-04-23 04:05PM
Apr-19-23 09:00AM
Apr-01-23 09:14AM
Mar-27-23 08:30AM
Mar-13-23 08:00AM
Mar-07-23 03:32PM
Mar-06-23 09:00AM
Mar-01-23 08:00AM
Feb-17-23 06:45AM
Feb-16-23 10:50AM
Feb-13-23 08:00AM
Feb-03-23 08:00AM
Jan-16-23 05:05AM
05:31PM Loading…
Dec-16-22 05:31PM
Dec-11-22 12:37PM
Dec-09-22 09:04AM
Dec-06-22 09:35AM
Nov-29-22 08:30AM
Nov-09-22 08:00AM
Nov-01-22 04:05PM
Oct-19-22 07:13AM
Oct-18-22 04:05PM
Oct-11-22 04:05PM
Aug-29-22 04:05PM
Aug-17-22 11:20AM
Aug-16-22 04:05PM
Jul-05-22 04:05PM
Jun-28-22 04:05PM
Jun-20-22 08:20AM
Jun-06-22 08:00AM
May-27-22 04:05PM
May-17-22 04:05PM
May-06-22 04:05PM
May-02-22 04:05PM
Apr-26-22 11:01PM
Apr-25-22 04:05PM
Apr-21-22 04:05PM
Apr-14-22 09:55AM
Mar-08-22 08:00AM
Feb-28-22 04:05PM
Feb-15-22 08:00AM
Feb-07-22 08:00AM
Dec-29-21 05:37AM
Dec-09-21 12:30PM
Nov-19-21 04:05PM
Nov-08-21 04:15AM
Nov-04-21 08:00AM
Nov-01-21 04:05PM
Oct-28-21 04:05PM
Oct-04-21 08:00AM
Sep-09-21 04:30PM
Aug-03-21 08:00AM
Jul-18-21 11:39AM
Jun-30-21 08:00AM
Jun-17-21 11:15PM
Ambrx Biopharma Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cormorant Asset Management, LP10% OwnerSep 18Buy9.24751,2336,944,92469,465,823Sep 19 04:49 PM
Cormorant Asset Management, LP10% OwnerSep 15Buy9.051,401,50512,680,67768,714,590Sep 19 04:49 PM
Cormorant Asset Management, LP10% OwnerApr 20Buy11.60886,63410,285,22067,313,085Apr 20 06:04 PM
Cormorant Asset Management, LP10% OwnerApr 19Buy11.15951,90910,612,35766,426,451Apr 20 06:04 PM
Cormorant Asset Management, LP10% OwnerApr 18Buy11.273,376,64638,053,11265,474,542Apr 20 06:04 PM
Cormorant Asset Management, LP10% OwnerApr 17Buy10.67562,1215,999,46162,097,896Apr 17 05:46 PM
Cormorant Asset Management, LP10% OwnerApr 14Buy9.96841,9678,384,30761,535,775Apr 17 05:46 PM
Cormorant Asset Management, LP10% OwnerApr 13Buy9.161,193,80810,935,52060,693,808Apr 17 05:46 PM
Cormorant Asset Management, LP10% OwnerMar 16Buy10.15500,0005,074,25053,500,000Mar 16 06:04 PM
Cormorant Asset Management, LP10% OwnerMar 15Buy10.60250,0002,648,87553,000,000Mar 16 06:04 PM
Cormorant Asset Management, LP10% OwnerMar 14Buy9.95250,0002,488,27552,750,000Mar 16 06:04 PM